Skip NavigationSkip to Content

Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L

  1. Author:
    Lee, J. K.
    Seki, N.
    Sayers, T. J.
    Subleski, J.
    Gruys, E. M.
    Murphy, W. J.
    Wiltrout, R. H.
  2. Author Address

    NCI, Lab Expt Immunol, Canc Res Ctr, Frederick, MD 21701 USA. Natl Genome Res Inst, NIH, Eunpyung Ku, Seoul 122701, South Korea. Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 830, Japan. SAIC, Intramural Res Support Program, Frederick, MD 21702 USA. Univ Nevada, Sch Med, Dept Microbiol, Reno, NV 89557 USA Wiltrout, RH, NCI, Lab Expt Immunol, Canc Res Ctr, Frederick, MD 21701 USA
    1. Year: 2005
    2. Date: JUN
  1. Journal: Cellular Immunology
    1. 235
    2. 2
    3. Pages: 145-152
  2. Type of Article: Article
  1. Abstract:

    CD40, a member of the TNF receptor superfamily, is expressed on B cells, dendritic cells, and some tumor cells, including melanoma and bladder carcinoma. In this study, we report that both mouse and human renal carcinoma cells (RCC) also constitutively express functional CD40. Treatment of mouse RCC with CD40L induced strong expression of genes and proteins for ICAM-1 and Fas, and this expression was further enhanced by combining CD40L with IFN-gamma. Similar effects were demonstrated using an agonist anti-CD40 antibody. The increased levels of Fas expression on RCC after treatment with CD40L plus IFN-gamma resulted in potent killing by either FasL-positive effector cells or agonistic anti-Fas antibody. The combination of CD40L plus IFN-gamma also significantly enhanced killing of RCC by tumor-specific CTL lines. Our results demonstrate that constitutively expressed CD40 is functionally active and may provide a molecular target for the development of new approaches to the treatment of RCC. Published by Elsevier lnc

    See More

External Sources

  1. DOI: 10.1016/j.cellimm.2005.08.029
  2. WOS: 000233533100008

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel